GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor

Analyse Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6KDZ
Type
protein
Length
648 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9Y233
Ligands
D79, ZN, MG
Pockets
9 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 70% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein32470% helix, 0% strandQ9Y233

Ligands and binding sites

  • D79 · 4-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]-3,7,8,10-tetrazatricyclo[7.4.0.0^{2, 7}]trideca-1,3,5,8,10,12-hexaen-6-ol · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17180.760.8064MG, D79
24590.720.8250MG
35580.710.8048empty
4830.590.8822empty
51730.440.7424empty

Interfaces

1 interface between chains.

  • A–B · 918 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 6KDZ · Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.